First Time Loading...
A

Abbott India Ltd
NSE:ABBOTINDIA

Watchlist Manager
Abbott India Ltd
NSE:ABBOTINDIA
Watchlist
Price: 25 820.0508 INR -1.19% Market Closed
Updated: May 6, 2024
Section:
 

Relative Value

The Relative Value of one ABBOTINDIA stock under the Base Case scenario is 22 096.2937 INR. Compared to the current market price of 25 820.0508 INR, Abbott India Ltd is Overvalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABBOTINDIA Relative Value
Base Case
22 096.2937 INR
Overvaluation 14%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

12.4
P/S
P/S
Price to Sales
12.4
vs History
4
vs Industry
13
Median 3Y
8.6
Median 5Y
8
Industry
2.5
Forward
9.2
More Details
60
P/E
P/E
Price to Earnings
60
vs History
11
vs Industry
7
Median 3Y
50.4
Median 5Y
49.1
Industry
23.4
Forward
45.2
More Details
175.1
P/OCF
P/OCF
Price to OCF
175.1
vs History
4
vs Industry
2
Median 3Y
50.7
Median 5Y
49.2
Industry
17.4
More Details
182.7
P/FCFE
P/FCFE
Price to FCFE
182.7
vs History
4
vs Industry
4
Median 3Y
56.5
Median 5Y
54.9
Industry
23.6
More Details
17.6
P/B
P/B
Price to Book Value
17.6
vs History
9
vs Industry
3
Median 3Y
15.9
Median 5Y
14.8
Industry
2.1
More Details
12.4
EV/S
EV/S
Enterprise Value to Sales
12.4
vs History
4
vs Industry
12
Median 3Y
8.2
Median 5Y
7.5
Industry
2.6
Forward
9.2
More Details
27.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
27.5
vs History
4
vs Industry
7
Median 3Y
18.2
Median 5Y
17
Industry
5.2
More Details
51.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
51.2
vs History
4
vs Industry
6
Median 3Y
36.8
Median 5Y
35.6
Industry
13.7
Forward
36.3
More Details
51.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
51.2
vs History
4
vs Industry
7
Median 3Y
39
Median 5Y
37.8
Industry
17.2
Forward
36.3
More Details
175
EV/OCF
EV/OCF
Enterprise Value to OCF
175
vs History
4
vs Industry
2
Median 3Y
48.6
Median 5Y
46.5
Industry
16.2
More Details
182.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
182.8
vs History
4
vs Industry
4
Median 3Y
50.6
Median 5Y
48.8
Industry
17.8
More Details
15.4
EV/IC
EV/IC
Enterprise Value to IC
15.4
vs History
90
vs Industry
8
Median 3Y
33.9
Median 5Y
38
Industry
2
More Details

Multiples Across Competitors

ABBOTINDIA Competitors Multiples
Abbott India Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Abbott India Ltd
NSE:ABBOTINDIA
548.7B INR 12.4 60 51.2 51.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
698.5B USD 19.4 113.8 55.8 63.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.8T DKK 16.3 45.2 33.1 36.1
US
Johnson & Johnson
NYSE:JNJ
359.3B USD 4.2 9.3 11.5 15
US
Merck & Co Inc
NYSE:MRK
322.8B USD 5.3 140 33.3 52.8
UK
AstraZeneca PLC
LSE:AZN
186.8B GBP 5.1 39.4 140.7 225.7
CH
Novartis AG
SIX:NOVN
181.4B CHF 4.3 13.5 9.9 16.3
CH
Roche Holding AG
SIX:ROG
174.1B CHF 3 15.1 8.6 10.2
US
Pfizer Inc
NYSE:PFE
157B USD 2.9 -508.1 12.6 20.1
P/E Multiple
Earnings Growth
IN
A
Abbott India Ltd
NSE:ABBOTINDIA
Average P/E: 54.5
60
69%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
113.8
346%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
45.2
84%
US
Johnson & Johnson
NYSE:JNJ
9.3
-20%
US
Merck & Co Inc
NYSE:MRK
140
7 454%
UK
AstraZeneca PLC
LSE:AZN
39.4
168%
CH
Novartis AG
SIX:NOVN
13.5
15%
CH
Roche Holding AG
SIX:ROG
15.1
26%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -508.1
680%

See Also

Summary
ABBOTINDIA intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABBOTINDIA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABBOTINDIA stock valuation using valuation multiples.
Wall Street Estimates
ABBOTINDIA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABBOTINDIA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.